Citi Pharma (CPHL) Q1-Sep25 financial update:
Earnings per share (EPS) for Q1 stood at Rs. 0.9, reflecting a decrease of 9 percent compared to the average of the preceding four quarters, yet showing a 1 percent increase year on year.
Revenue for the first quarter rose by 2 percent over the average of the previous four quarters and increased 5 percent year on year.
Gross profit climbed 3 percent relative to the previous four quarters' average and grew 21 percent year on year. The gross profit margin held steady at 15 percent in the latest quarter, consistent with the four-quarter average.
The tax rate for Q1 was 33 percent, slightly below the prior four quarters' average of 34 percent. Additionally, other income from the quarter was Rs. 28.7 million. No dividend was declared for this period.
No dividend declared